AUTHORS
Gabriel Karin, N/A, Veena Sangkhae, PhD2, Heidi Schmidt, PhD3, Vida Zhang, PhD4, Elizabeth J. Tarling, PhD5, Thomas Vallim, PhD6, Elizabeth Nemeth, PhD7, Tomas Ganz, MD, PhD8
AFFILIATIONS
1 David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, California, United States
2 David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, California, United States
3 David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, California, United States
4 David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, California, United States
5 David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, California, United States
6 David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, California, United States
7 David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, California, United States
8 David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, California, United States
ABSTRACT
Rationale and Methods: Previous studies document that iron deficiency prevents normal weight gain in children and piglets, an effect reversed by iron supplementation. We investigated the mechanisms by which iron restriction decreases weight gain. Mice were placed on a low-iron (4 ppm) diet at weaning, and iron mobilization was prevented by raising iron-regulatory hormone hepcidin levels through weekly injections of Tmprss6 antisense oligonucleotide (ASO). Obesity models were fed iron-depleted (4 ppm) or iron-replete (100 ppm) high-fat diets (HFD) for 15 weeks. A subset of mice was monitored in metabolic cages to measure food and water consumption, locomotor activity, respiratory parameters, and energy balance. Unabsorbed energy substrates were measured by bomb calorimetry of collected feces.
Results: After 6 weeks of severe iron restriction, achieved by combined low-iron diet and Tmprss6 ASO, male mice were protected against HFD-induced obesity. Female mice exhibited the same findings with a 3-week delay. In male mice at 15 weeks, severe iron restriction caused a drastic reduction in body mass accumulation (4 ppm HFD: control vs. Tmprss6 ASO: 44.4 g vs. 30.2 g; 100 ppm HFD: control vs. Tmprss6 ASO: 48.4 g vs. 46.2 g). The deficit in body mass represented a selective lack of adipose tissue expansion, with lean body mass unaffected, as measured by body NMR and micro-CT scanning.
Tmprss6 ASO-treated mice on HFD developed microcytic anemia, which was more severe on the 4 ppm than 100 ppm diet (week 15 Hb: 5.7 g/dL vs. 10.0 g/dL). Serum erythropoietin (EPO) concentrations were extremely high in the Tmprss6 ASO 4 ppm group (control ASO 4 ppm vs. 100 ppm: 7580 pg/mL vs. 88 pg/mL; Tmprss6 ASO 4 ppm vs. 100 ppm: 12320 pg/mL vs. 890 pg/mL). Although prior studies (Yin et al. Nat Commun. 2024;15:8114) showed high serum EPO interacting with adipose EPO receptors (EpoR) to inhibit fat accumulation, neither adipose-specific EpoR ablation nor the nonerythroid EpoR antagonist Emp9 interfered with the anti-obesity effect in our models. Furthermore, while adipocyte iron deficiency has been implicated in fat depot loss (Zhang et al. Cell Metab. 2021;33:1624), unilateral local injection of iron sufficient to correct the local iron deficit in the inguinal fat depot did not restore fat depots.
Long-term indirect calorimetry studies investigated the metabolic effects of a low-iron/high-fat diet combined with Tmprss6 or control ASO. Weight and fat mass gain in Tmprss6 ASO-treated male mice plateaued and diverged from control mice after 5 weeks of treatment. By that time, Tmprss6 ASO-treated mice showed lower cumulative food intake and higher cumulative locomotion.
Iron deficiency inhibits mucosal epithelial repair (Huang et al. J Nutr. 2024;154:1153), and failure to repair mechanical or chemical injury could lead to nutrient malabsorption. However, bomb calorimetry revealed no significant differences in residual fecal energy density or calculated fractional energy substrate absorption, arguing against nutrient malabsorption as a cause of resistance to obesity.
Discussion: Our findings demonstrate that severe systemic iron restriction, achieved by combining a low-iron diet with Tmprss6 ASO to prevent iron mobilization, exerts a potent protective effect against HFD-induced obesity in mice. This effect selectively prevents adipose tissue expansion while preserving lean body mass. The anti-obesity effect operates independently of adipose EPO-EpoR signaling, local adipocyte iron depletion, or malabsorption of energy substrates. Instead, metabolic cage analyses indicate that protection is driven by altered energy balance, characterized by reduced cumulative food intake and increased locomotor activity.
Conclusions: Severe iron restriction prevents HFD-induced obesity in mouse models primarily through appetite suppression and enhanced physical activity. These results elucidate the complex metabolic adaptations to severe iron deficiency and highlight the key role of systemic iron homeostasis in regulating energy balance and adiposity.
DISCLOSURES
Gabriel Karin, N/A: No relevant conflicts of interest to declare.